NCT06578260 Support Groups - a Model for Social Inclusion and Reduction of Bullying in School
| NCT ID | NCT06578260 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Oslo Metropolitan University |
| Condition | Bullying |
| Study Type | INTERVENTIONAL |
| Enrollment | 1,586 participants |
| Start Date | 2024-11-01 |
| Primary Completion | 2025-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 1,586 participants in total. It began in 2024-11-01 with a primary completion date of 2025-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Study Title: Support Groups - a model for social inclusion and reduction of bullying in school Study Design: Cluster Randomized Controlled trial (CRCT) Objective: To investigate the effectiveness of a support group intervention using a solution-focused approach among school children in 5th-7th grade in southeastern Norway Intervention: Peer support groups with a solution-focused approach Study Population: School Children
Eligibility Criteria
Inclusion Criteria: * Primary Schools with more than 200 students * Public Health Nurse employed in a 50% position or more Exclusion Criteria: * Primary Schools with less than 200 students
Contact & Investigator
Lisbeth Valla, Phd
PRINCIPAL INVESTIGATOR
OsloMet
Frequently Asked Questions
Who can join the NCT06578260 clinical trial?
This trial is open to participants of all sexes, aged 10 Years or older, up to 12 Years, studying Bullying. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06578260 currently recruiting?
Yes, NCT06578260 is actively recruiting participants. Contact the research team at lisval@oslomet.no for enrollment information.
Where is the NCT06578260 trial being conducted?
This trial is being conducted at Oslo, Norway.
Who is sponsoring the NCT06578260 clinical trial?
NCT06578260 is sponsored by Oslo Metropolitan University. The principal investigator is Lisbeth Valla, Phd at OsloMet. The trial plans to enroll 1,586 participants.